Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NFH
1201
CALL
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
| $22.5M | 0.01% |
7,614,500
+189,500
| +3% | +$2.11M |
|
|
XLRN
1202
PUT
DELISTED
Acceleron Pharma
XLRN
| $22.3M | 0.01% |
+129,600
| New | +$17M |
|
1203
CenterPoint Energy
CNP
$25.8B
| $22.3M | 0.01% |
904,669
+545,778
| +152% | +$14M |
|
|
REVH
1204
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
| $22.2M | 0.01% |
2,291,156
+1,712,653
| +296% | +$16.7M |
|
1205
Travelers Companies
TRV
$76.8B
| $22.2M | 0.01% |
146,175
-71,780
| -33% | -$11.1M |
|
1206
Bumble
BMBL
$371M
| $22.2M | 0.01% |
443,891
+331,641
| +295% | +$17.2M |
|
1207
Bath & Body Works
BBWI
$3.75B
| $22.2M | 0.01% |
351,934
-220,524
| -39% | -$14M |
|
1208
Monolithic Power Systems
MPWR
$64.1B
| $22.2M | 0.01% |
45,751
+24,500
| +115% | +$11.1M |
|
|
RWT
1209
Redwood Trust
RWT
$592M
| $22.1M | 0.01% |
1,717,290
+1,215,554
| +242% | +$14.9M |
|
1210
Jefferies Financial Group
JEF
$11.9B
| $22.1M | 0.01% |
623,310
+495,385
| +387% | +$16.6M |
|
1211
Twilio
TWLO
$34.6B
| $22.1M | 0.01% |
69,224
-126,447
| -65% | -$46M |
|
|
APGB
1212
DELISTED
Apollo Strategic Growth Capital II
APGB
| $22.1M | 0.01% |
2,259,136
+973,205
| +76% | +$9.46M |
|
1213
Vail Resorts
MTN
$5.3B
| $22.1M | 0.01% |
66,055
+61,299
| +1,289% | +$18.9M |
|
1214
Toast
TOST
$21.3B
| $22M | 0.01% |
+441,409
| New | +$24.1M |
|
|
PINC
1215
DELISTED
Premier
PINC
| $22M | 0.01% |
567,509
+510,228
| +891% | +$18.8M |
|
1216
iShares MSCI South Korea ETF
EWY
$27.8B
| $22M | 0.01% |
+272,259
| New | +$23.7M |
|
1217
Elanco Animal Health
ELAN
$12.3B
| $21.9M | 0.01% |
686,279
-640,884
| -48% | -$21.5M |
|
1218
Petrobras
PBR
$115B
| $21.9M | 0.01% |
2,115,546
+1,670,871
| +376% | +$17.8M |
|
1219
Planet Labs
PL
$7.66B
| $21.9M | 0.01% |
2,206,102
+194,349
| +10% | +$1.92M |
|
1220
W.W. Grainger
GWW
$61.7B
| $21.8M | 0.01% |
55,505
-2,237
| -4% | -$971K |
|
|
WIRE
1221
DELISTED
Encore Wire Corp
WIRE
| $21.8M | 0.01% |
229,966
+148,654
| +183% | +$12.2M |
|
1222
Yum China
YUMC
$16.4B
| $21.8M | 0.01% |
372,792
+352,284
| +1,718% | +$21.7M |
|
|
EOSEW
1223
CALL
Eos Energy Enterprises Warrant
EOSEW
$29.4M
| $21.7M | 0.01% |
4,318,200
+534,990
| +14% | +$3.11M |
|
1224
KB Home
KBH
$3.42B
| $21.7M | 0.01% |
557,630
-915,810
| -62% | -$38M |
|
1225
Establishment Labs
ESTA
$2.14B
| $21.7M | 0.01% |
303,144
+188,134
| +164% | +$13.9M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.